title: Thrombolysis in the 3- to 4.5-hour window: what do ECASSkeptics want?
authors: From the Stroke Division, Beth Israel Deaconess Medical Center, Boston, MA (M.H.S.); and Stroke Unit, Department of Neurology, Hospital Vall d'Hebron-Barcelona, Barcelona, Spain (C.A.M.).
authors: Magdy H
authors: MH
authors: Selim
authors: Carlos A
authors: CA
authors: Molina
mesh_terms: D005343:Fibrinolytic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D007275:Injections, Intravenous; D020521:Stroke / Q000188:drug therapy*; D015912:Thrombolytic Therapy / Q000379:methods*; D013997:Time Factors; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage / Q000627:therapeutic use*; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator
keywords: stroke; tissue plasminogen activator